Rolipram
From Wikipedia, the free encyclopedia
Rolipram
|
|
Systematic (IUPAC) name | |
4-(3-cyclopentyloxy-4-methoxy-phenyl)pyrrolidin-2-one | |
Identifiers | |
CAS number | 61413-54-5 |
ATC code | ? |
PubChem | 5092 |
DrugBank | EXPT00228 |
Chemical data | |
Formula | C16H21NO3 |
Mol. weight | 275.347 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Rolipram is a PDE4-inhibitor. Like most PDE4-inhibitors, it is an anti-inflammatory drug.[1] Rolipram is being researched as a possible alternative to current antidepressants.[2][3] A recent study shows that rolipram may have antipsychotic effects.[4]
[edit] References
- ^ Griswold DE, Webb EF, Breton J, White JR, Marshall PJ, Torphy TJ. (1993). "Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.". Inflammation. 17 (3): 333–44. PMID 7687237.
- ^ Bobon D, Breulet M, Gerard-Vandenhove MA, Guiot-Goffioul F, Plomteux G, Sastre-y-Hernandez M, Schratzer M, Troisfontaines B, von Frenckell R, Wachtel H. (1988). "Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives.". Eur Arch Psychiatry Neurol Sci. 238 (1): 2–6. PMID 3063534.
- ^ Wachtel H. (1983). "Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.". Neuropharmacology. 22 (3): 267–72. PMID 6302550.
- ^ Kanes SJ, Tokarczyk J, Siegel SJ, Bilker W, Abel T, Kelly MP. (2006). "Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.". Neuroscience. ? (?): ?. PMID 17081698.
Selective Phosphodiesterase inhibitors (C01CE, G04BE)edit | ||
---|---|---|
PDE1: | ||
PDE2: | ||
PDE3: | ||
PDE4: |
Rolipram |
|
PDE5: |